Publications 2010-2016

• Bennett JM, Tuechler H, Aul C, Strupp C, Germing U. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?). Leuk Res. 2016;47:63-69.
• Braulke, F., Platzbecker, U., Mueller-Thomas, C., Goetze, K., Germing, U., Bruemmendorf, T.H., Nolte, F., Hofmann, W.-K., Giagounidis, A.A.N., Luebbert, M., Greenberg, P.L., Bennett, J.M., Sole, F., Mallo, M., Slovak, M.L., Ohyashiki, K., Le Beau, M.M., Tuechler, H., Pfeilstoecker, M., Noesslinger, T., Hildebrandt, B., Shirneshan, K., Aul, C., Stauder, R., Sperr, W.R., Valent, P., Fonatsch, C., Truemper, L., Haase, D., Schanz, J., 2015. Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group. Haematologica 100, 205-213.
• Della Porta, M.G., Tuechler, H., Malcovati, L., Schanz, J., Sanz, G., Garcia-Manero, G., Sole, F., Bennett, J.M., Bowen, D., Fenaux, P., Dreyfus, F., Kantarjian, H., Kuendgen, A., Levis, A., Cermak, J., Fonatsch, C., Le Beau, M.M., Slovak, M.L., Krieger, O., Luebbert, M., Maciejewski, J., Magalhaes, S.M.M., Miyazaki, Y., Pfeilstoecker, M., Sekeres, M.A., Sperr, W.R., Stauder, R., Tauro, S., Valent, P., Vallespi, T., van de Loosdrecht, A.A., Germing, U., Haase, D., Greenberg, P.L., Cazzola, M., 2015. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM). Leukemia.
• Greenberg, P.L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Sole, F., Bennett, J.M., Bowen, D., Fenaux, P., Dreyfus, F., Kantarjian, H., Kuendgen, A., Levis, A., Malcovati, L., Cazzola, M., Cermak, J., Fonatsch, C., Le Beau, M.M., Slovak, M.L., Krieger, O., Luebbert, M., Maciejewski, J., Magalhaes, S.M.M., Miyazaki, Y., Pfeilstoecker, M., Sekeres, M., Sperr, W.R., Stauder, R., Tauro, S., Valent, P., Vallespi, T., van de Loosdrecht, A.A., Germing, U., Haase, D., 2012. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120, 2454-2465.
• Greenberg, P.L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Sole, F., Bennett, J.M., Bowen, D., Fenaux, P., Dreyfus, F., Kantarjian, H., Kuendgen, A., Levis, A., Malcovati, L., Cazzola, M., Cermak, J., Fonatsch, C., Le Beau, M.M., Slovak, M.L., Krieger, O., Luebbert, M., Maciejewski, J., Magalhaes, S.M.M., Miyazaki, Y., Pfeilstoecker, M., Sekeres, M., Sperr, W.R., Stauder, R., Tauro, S., Valent, P., Vallespi, T., van de Loosdrecht, A.A., Germing, U., Haase, D., Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes. Blood. August 2016. doi: 10.1182/blood-2016-07-728766.
• Kisser A, Tüchler H, Erdös J, Wild C. Factors influencing coverage decisions on medical devices: A retrospective analysis of 78 medical device appraisals for the Austrian hospital benefit catalogue 2008-2015. Health Policy. June 2016. doi: 10.1016/j.healthpol.2016.06.007.
• Machherndl-Spandl, S., Sega, W., Boesmueller, H., Germing, U., Gruber, C., Nachtkamp, K., Reinecke, P., Sperr, W.R., Wimazal, F., Muellauer, L., Sotlar, K., Horny, H.P., Tuechler, H., Valent, P., Krieger, O., 2014. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis. Ann. Hematol. 93, 57-64.
• Noesslinger, T., Tuechler, H., Germing, U., Sperr, W.R., Krieger, O., Haase, D., Luebbert, M., Stauder, R., Giagounidis, A., Valent, P., Pfeilstoecker, M., 2010. Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes. Ann. Oncol 21, 120-125.
• Pfeilstöcker M, Tuechler H, Sanz G, et al. Time-dependent changes in mortality and transformation risk in MDS. Blood. June 2016.
• Pfeilstoecker, M., Tuechler, H., Schoenmetzler, A., Noesslinger, T., Pittermann, E., 2011. Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes. Leuk Res.
• Piso, B., Tuechler, H., Gyimesi, M., Kollmann, I., Endel, G., Wilbacher, I., Kurz, R.W., Mueller, R., 2011. Ambulante kardiologische Phase-III-Rehabilitation - retrospektive Kohortenstudie zu einer Wiener Einrichtung[Outpatient cardiac phase III rehabilitation at a Viennese institution - retrospective cohort study]. Wien Med Wochenschr 161, 263-271.
• Piso B, Tuechler H, Kawalirek S, Yazigi M, Mueller R, 2012. Multizentrische, prospektive Kohortenstudie zur ambulanten kardiologischen Phase-III-Rehabilitation - Ein Studienprotokoll. Journal of Cardiology, 19, Pre Publishing Online.
• Rosenmayr, A., Pointner-Prager, M., Mitterschiffthaler, A., Bozic, L., Pelzmann, B., Tuechler, H., Fae, I., Fischer, G.F., Greinix, H.T., Peters, C., Kalhs, P., Krieger, O., Linkesch, W., Nachbaur, D., Urban, C., Posch, U., Lanzer, G., Gabriel, C., Schennach, H., Mayr, W.R., 2011. What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country. Bone Marrow Transplantation 47, 172-180.
• Rosenmayr, A., Pointner-Prager, M., Winkler, M., Mitterschiffthaler, A., Pelzmann, B., Bozic, L., Pichler, S.-K., Tuechler, H., Fae, I., Fischer, G., 2011. The Austrian Bone Marrow Donor Registry: Providing Patients in Austria with Unrelated Donors for Transplant - a Worldwide Cooperation. Transfus Med Hemother 38, 292-299.
• Schanz, J., Steidl, C., Fonatsch, C., Pfeilstoecker, M., Noesslinger, T., Tuechler, H., Valent, P., Hildebrandt, B., Giagounidis, A., Aul, C., Luebbert, M., Stauder, R., Krieger, O., Garcia-Manero, G., Kantarjian, H., Germing, U., Haase, D., Estey, E., 2011. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. J. Clin. Oncol. 29, 1963-1970.
• Schanz, J., Tuechler, H., Sole, F., Mallo, M., Luno, E., Cervera, J., Granada, I., Hildebrandt, B., Slovak, M.L., Ohyashiki, K., Steidl, C., Fonatsch, C., Pfeilstoecker, M., Noesslinger, T., Valent, P., Giagounidis, A., Aul, C., Luebbert, M., Stauder, R., Krieger, O., Garcia-Manero, G., Faderl, S., Pierce, S., Le Beau, M.M., Bennett, J.M., Greenberg, P., Germing, U., Haase, D., 2012. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J. Clin. Oncol. 30, 820-829.
• Schanz, J., Tuechler, H., Sole, F., Mallo, M., Luno, E., Cervera, J., Grau, J., Hildebrandt, B., Slovak, M.L., Ohyashiki, K., Steidl, C., Fonatsch, C., Pfeilstoecker, M., Noesslinger, T., Valent, P., Giagounidis, A., Aul, C., Luebbert, M., Stauder, R., Krieger, O., Beau, M.M.L., Bennett, J.M., Greenberg, P., Germing, U., Haase, D., 2013. Monosomal karyotype in MDS: explaining the poor prognosis? Leukemia 27, 1988-1995.
• Zechmeister-Koss I, Winkler R, Fritz C, Thun-Hohenstein L. Services Use of Children and Adolescents before Admission to Psychiatric Inpatient Care. ICMPE. 2016;19(2):103-113.